RNA-seq analysis of the human SCLC cell line CORL47 revealed high expression of HLA-B and HLA-C in ZFP36L1-activated SCLC, indicating an increased number of antigenic peptides on the tumor cell surface, making these tumors potentially more sensitive to T-cell-based immunotherapies (94). The gene discussed is HLA-B; the disease is small cell lung carcinoma.